Axogen, Inc. (AXGN) › Capital ExpendituresAxogen, Inc. (AXGN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $20.6K2012: $48.5K2013: $178.8K2014: $542.0K2015: $408.8K2016: $931.0K2017: $1.10M2018: $6.28M2019: $4.66M2020: $21.91M2021: $27.81M2022: $20.08M2023: $13.87M2024: $3.10M2025: $3.75M$3.75M2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$3.75M+20.8%2024$3.10M-77.6%2023$13.87M-30.9%2022$20.08M-27.8%2021$27.81M+27.0%2020$21.91M+369.7%2019$4.66M-25.8%2018$6.28M+468.5%2017$1.10M+18.7%2016$931.0K+127.7%2015$408.8K-24.6%2014$542.0K+203.2%2013$178.8K+268.9%2012$48.5K+135.1%2011$20.6K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share